PP
MGNX icon

PDT Partners’s MacroGenics MGNX Stock Holding History

PDT Partners’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-27,389
Closed -$89K – 814
2024
Q4 		$89K Sell
27,389
-132,650
-83% -$478K 0.01% 693
2024
Q3 		$527K Buy
160,039
+49,288
+45% +$192K 0.05% 495
2024
Q2 		$471K Buy
+110,751
New +$1.08M 0.04% 476
2023
Q1 		– Sell
-46,526
Closed -$312K – 661
2022
Q4 		$312K Sell
46,526
-63,528
-58% -$348K 0.05% 478
2022
Q3 		$381K Sell
110,054
-76,721
-41% -$293K 0.06% 514
2022
Q2 		$551K Buy
186,775
+46,450
+33% +$244K 0.05% 571
2022
Q1 		$1.24M Buy
+140,325
New +$1.55M 0.11% 306
2021
Q3 		– Sell
-74,014
Closed -$1.99M – 853
2021
Q2 		$1.99M Buy
74,014
+22,788
+44% +$667K 0.13% 270
2021
Q1 		$1.63M Sell
51,226
-22,774
-31% -$553K 0.12% 290
2020
Q4 		$1.69M Hold
74,000
– – 0.11% 263
2020
Q3 		$1.86M Buy
74,000
+28,100
+61% +$767K 0.12% 223
2020
Q2 		$1.28M Buy
+45,900
New +$797K 0.09% 245
2014
Q2 		– Sell
-14,623
Closed -$407K – 1535
2014
Q1 		$407K Buy
+14,623
New +$516K 0.01% 1035

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PDT Partners's MGNX Position: Q1 2025 in Review

PDT Partners sold out of MacroGenics (MGNX) in Q1 2025, closing a stake of 27,389 shares — an estimated $89K sold.

PDT Partners first reported a position in MGNX in Q1 2014 and held it in 13 quarters. The position peaked at $1.99M in Q2 2021. 128 funds tracked by Wall St. Rank hold MGNX as of Q1 2025.

  • PDT Partners reported no remaining MacroGenics position as of Q1 2025 after selling out during the quarter.
  • PDT Partners sold 27,389 MacroGenics shares in Q1 2025, an estimated $89K.
  • PDT Partners first reported a position in MacroGenics in Q1 2014 and held it in 13 quarters.
  • PDT Partners's MacroGenics position peaked at $1.99M in Q2 2021.
  • 128 funds tracked by Wall St. Rank held MacroGenics as of Q1 2025.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.